[HTML][HTML] RdRp inhibitors and COVID-19: Is molnupiravir a good option?
SMR Hashemian, MH Pourhanifeh, MR Hamblin… - Biomedicine & …, 2022 - Elsevier
Rapid changes in the viral genome allow viruses to evade threats posed by the host immune
response or antiviral drugs, and can lead to viral persistence in the host cells. RNA …
response or antiviral drugs, and can lead to viral persistence in the host cells. RNA …
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
AS Lokhande, PV Devarajan - European Journal of Pharmacology, 2021 - Elsevier
The global pandemic of Coronavirus Disease 2019 (COVID-19) has brought the world to a
grinding halt. A major cause of concern is the respiratory distress associated mortality …
grinding halt. A major cause of concern is the respiratory distress associated mortality …
Nitro-group-containing drugs
K Nepali, HY Lee, JP Liou - Journal of medicinal chemistry, 2018 - ACS Publications
The nitro group is considered to be a versatile and unique functional group in medicinal
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …
Treatment-refractory giardiasis: challenges and solutions
Giardia is the commonest parasitic diarrheal pathogen affecting humans and a frequent
cause of waterborne/foodborne parasitic diseases worldwide. Prevalence of giardiasis is …
cause of waterborne/foodborne parasitic diseases worldwide. Prevalence of giardiasis is …
Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis
R Argüello-García, D Leitsch, T Skinner-Adams… - Advances in …, 2020 - Elsevier
The use of chemotherapeutic drugs is the main resource against clinical giardiasis due to
the lack of approved vaccines. Resistance of G. duodenalis to the most used drugs to treat …
the lack of approved vaccines. Resistance of G. duodenalis to the most used drugs to treat …
Anti-Giardia Drug Discovery: Current Status and Gut Feelings
Giardia parasites are ubiquitous protozoans of global importance that impact a wide range
of animals including humans. They are the most common enteric pathogen of cats and dogs …
of animals including humans. They are the most common enteric pathogen of cats and dogs …
Giardiasis: characteristics, pathogenesis and new insights about treatment
V Vivancos, I González-Alvarez… - Current topics in …, 2018 - ingentaconnect.com
Giardia intestinalis infection causes enterocytes damage and loss of brush border of the
epithelial cells of the intestine that leads to shortening of microvilli and altered epithelial …
epithelial cells of the intestine that leads to shortening of microvilli and altered epithelial …
Design, classification, and adverse effects of NSAIDs: A review on recent advancements
Inflammation is a hallmark of many diseases, including cancer, neurodegenerative diseases
like Alzheimer's, type II diabetes, rheumatoid arthritis, and asthma. Nonsteroidal anti …
like Alzheimer's, type II diabetes, rheumatoid arthritis, and asthma. Nonsteroidal anti …
Drug discovery for cutaneous leishmaniasis: a review of developments in the past 15 years
HN Corman, CW McNamara, MA Bakowski - Microorganisms, 2023 - mdpi.com
Leishmaniasis is a group of vector-borne, parasitic diseases caused by over 20 species of
the protozoan Leishmania spp. The three major disease classifications, cutaneous, visceral …
the protozoan Leishmania spp. The three major disease classifications, cutaneous, visceral …
Structural Insight into Privileged Heterocycles as Anti-Trypanosoma cruzi and brucei Agents
J Abbasi Shiran, M Ghanbari… - Current Topics in …, 2023 - benthamdirect.com
Trypanosomiasis is caused by parasitic protozoan trypanosomes in vertebrates. T. cruzi and
T. brucei are causative agents of Chagas disease (CD) and Human African …
T. brucei are causative agents of Chagas disease (CD) and Human African …